ALK and neuroblastoma: Gain‐of‐function mutations of ALK, which lead to constitutive ALK phosphorylation, are known to contribute to the aggressive nature of pediatric neuroblastoma tumors, and therefore, the detection of ALK activity in available neuroblastoma cell lines is of increasing importance.